New York, Aug. 4 - AtriCure, Inc. priced its $48 million initial public offering of 4 million shares of common stock at $12.00 per share.
The deal came at the low end of the most recent price range of $12.00 to $14.00 filed with the Securities and Exchange Commission.
UBS Investment Bank and Piper Jaffray & Co. were joint bookrunners for the offering. Thomas Weisel Partners LLC and A. G. Edwards & Sons, Inc. were co-managers.
The underwriters have a greenshoe for 150,000 shares from the company and 450,000 shares from selling shareholders.
AtriCure, a West Chester, Ohio, manufacturer of surgical devices, plans to use $6.5 million of the funds to acquire Enable Medical Corp., with the rest of the money set aside for general corporate purposes.
| Issuer: | AtriCure, Inc.
|
| Issue: | Stock (initial public offering)
|
| Amount: | $48 million
|
| Shares: | 4 million
|
| Price: | $12.00
|
| Greenshoe: | 600,000 shares
|
| Bookrunners: | UBS Investment Bank and Piper Jaffray & Co.
|
| Pricing date: | Aug. 4, after close
|
| Talk: | $12.00 to $14.00
|
| Symbol: | ATRC
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
